Acurx Pharmaceuticals, Inc. Common Stock
ACXPAcurx Pharmaceuticals, Inc. (ACXP) is a biopharmaceutical company focused on developing and commercializing therapies for infections, with an emphasis on antibiotic-resistant bacteria. The company aims to address unmet medical needs by advancing innovative treatments to combat bacterial infections that threaten public health.
Company News
The global biodefense market is projected to grow from USD 16.81 billion in 2024 to USD 32.87 billion by 2034, driven by advancements in biotechnology, increased government funding, and growing awareness of biological threats.
Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expected sales for its first quarter. The company reported quarterly losses of 81 cents per share, according to data from Benzinga Pro. Alcoa still sees full-year alumina production of between 9.8 million and 10 million metr...
